Overview
Tayfun Elibol practices in Istanbul, Turkey. Elibol is rated as an Experienced expert by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Their top areas of expertise are Splenomegaly, Chronic Myelogenous Leukemia (CML), Primary Mediastinal B-Cell Lymphoma (PMBCL), and Leukemia.
Their clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Primary Mediastinal B-Cell Lymphoma (PMBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Blood ClotsElibol isExperienced. Learn about Blood Clots.
- Chronic Myelogenous Leukemia (CML)
- Essential ThrombocythemiaElibol isExperienced. Learn about Essential Thrombocythemia.
- LeukemiaElibol isExperienced. Learn about Leukemia.
- Paroxysmal Cold HemoglobinuriaElibol isExperienced. Learn about Paroxysmal Cold Hemoglobinuria.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)